Yep FHC, you are onto it.One of a number of hurdles are set at all heights prior to the due diligence completion. Anteo management inform that two MTA’s are ideal for the capacity of the current development team to respond with.
The early decision from the newly interested European collaborators to pass on their own technology for melding, trialing, and proving with the Anteo developments surprised me. The battery sector is under an intensely competitive arena so I guess this comes as part of the territory.
While charging cycles, shelf-life etc will use time for approvals, at least the energy industry is not subject to in-Vivo etc trials in the health industry.
Charting of numerous performance values will be settled within the two MTA’s and be available for newly interested collaborators to reduce the hurdles and enable more speedy conclusions. GLTA
